Research Progress Related to Raynaud’s Phenomenon

Investigators across the country, many supported by the National Institutes of Health, are working to find ways to improve blood flow in people with Raynaud’s phenomenon and to prevent tissue damage. A number of research efforts are focused on examining the efficacy of drugs known to cause blood vessel widening, such as statins and prostaglandins. Investigators are also testing new surgical procedures to treat Raynaud’s phenomenon.

For more info

U.S. Food and Drug Administration

Toll free: 888-INFO-FDA (888-463-6332)
Website: fda.gov

Drugs@FDA at https://www.accessdata.fda.gov/scripts/cder/dafDrugs@FDA is a searchable catalog of FDA-approved drug products. 

Centers for Disease Control and Prevention, National Center for Health Statistics

Website: cdc.gov/nchs (en inglés)

National Heart, Lung, and Blood Institute, National Institutes of Health

Website: https://www.nhlbi.nih.gov (en inglés)

American College of Rheumatology

Website: rheumatology.org (en inglés)

Arthritis Foundation

Website: arthritis.org (en inglés)

Lupus Foundation of America

Website: lupus.org (en inglés)

National Scleroderma Foundation

Website: scleroderma.org (en inglés)

Scleroderma Research Foundation

Website: srfcure.org (en inglés)

Sjögren's Foundation

Website: sjogrens.org (en inglés)

If you need more information about available resources in your language or other languages, please visit our webpages below or contact the NIAMS Information Clearinghouse at NIAMSInfo@mail.nih.gov. You can also find a variety of information from organizations that are NIAMS Coalition Members.

View/Download/Order Publications